Clinical Trial Update: Dose Ranging Study of the Effects of Alpha Lipoic Acid on Oxidative Stress [Phase 2]

View source ↗

Summary

Phase 2 dose-ranging trial evaluating the effects of alpha-lipoic acid on oxidative stress in metabolic syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome

Drugs mentioned

• Alpha Lipoic Acid (alpha-lipoic acid)

Snippet

Sponsor: Johns Hopkins University | Conditions: Metabolic Syndrome | Phase 2 | Status: COMPLETED